Vinpocetine and α-tocopherol prevent the increase in da and oxidative stress induced by 3-NPA in striatum isolated nerve endings

Journal of Neurochemistry

Volumn 124, Issue 2, 2013, Pages 233-240

  Herrera Mundo, Nieves ^a   Sitges, María ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

3 nitropropionic acid; dopamine quinone adducts; MAO; synaptosomes; vinpocetine; VMA

Indexed keywords

3 NITROPROPIONIC ACID; 3,4 DIHYDROXYPHENYLACETIC ACID; ALPHA TOCOPHEROL; DOPAMINE; REACTIVE OXYGEN METABOLITE; VINPOCETINE;

ANIMAL CELL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG MECHANISM; DRUG TARGETING; FLUORESCENCE ANALYSIS; LIPID PEROXIDATION; NERVE ENDING; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN; SYNAPSE VESICLE; SYNAPTOSOME;

ALPHA-TOCOPHEROL; ANIMALS; ANTICONVULSANTS; ANTIOXIDANTS; CORPUS STRIATUM; DOPAMINE; NERVE ENDINGS; NEURAL INHIBITION; NEUROPROTECTIVE AGENTS; NITRO COMPOUNDS; OXIDATIVE STRESS; PROPIONATES; RATS; VINCA ALKALOIDS;

EID: 84871614026     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12082     Document Type: Article

References (24)

1. Alexi T., Hughes P., Faull R., and, Williams C., (1998) 3-Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration. NeuroReport 9, R57-R64.
2. Araki T., Kato H., and, Kogure K., (1991) Comparative protective effects of vinconate, baclofen, and pentobarbital against neuronal damage following repeated brief cerebral ischemia in the gerbil brain. Res. Exp. Med. (Berl) 191, 371-378.
3. Borges C. R., Geddes T., Watson J. T., and, Kuhn D. M., (2002) Dopamine biosynthesis is regulated by S-glutathionylation. Potential mechanism of tyrosine hydroxylast inhibition during oxidative stress. J. Biol. Chem. 277, 48295-48302.
4. Brouillet E., Guyot M. C., Mittoux V., Altairac S., Condé F., Palfi S., and, Hantraye P., (1998) Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J. Neurochem. 70, 794-805.
5. Fu Y., He F., Zhang S., and, Jiao X., (1995) Consistent striatal damage in rats induced by 3-nitropropionic acid and cultures of arthrinium fungus. Neurotoxicol. Teratol. 17, 413-418.
6. Herrera-Mundo N., and, Sitges M., (2010) Mechanisms underlying striatal vulnerability to 3-nitropropionic acid. J. Neurochem. 114, 597-605.
7. Jana S., Maiti A. K., Bagh M. B., Banerjee K., Das A., Roy A., and, Chakrabarti S., (2007) Dopamine but not 3,4-dihydroxy phenyl acetic acid (DOPAC) inhibits brain respiratory chain activity bu autoxidation and mitochondria catalyzed oxidation to quinone products: Implications in Parkinson's disease. Brain Res. 1139, 195-200.
8. Khan F. H., Sen T., Maiti A. K., Jana S., Chatterjee U., and, Chakrabarti S., (2005) Inhibition of rat brain mitochondrial electron transport chain activity by dopamine oxidation products during extended in vitro incubation: Implications for Parkinson's disease. Biochim. Biophys. Acta 1741, 65-74.
9. King G. A., (1987) Protective effects of vinpocetine and structurally related drugs on the lethal consequences of hypoxia in mice. Arch. Int. Pharmacodyn. Ther. 286, 299-307.
10. Ludolph A. C., He F., Spencer P. S., Hammerstad J., and, Sabri M., (1991) 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin. Can. J. Neurol. Sci. 18, 492-498.
11. Morinan A., and, Garratt H. M., (1985) An improved fluorimetric assay for brain monoamine oxidase. J. Pharmacol. Methods 13, 213-223.
12. Oláh V. A., Balla G., Balla J., Szabolcs A., and, Karmazsin L., (1990) An in vitro study of the hydroxyl scavenger effect of Cavinton. Acta Paediatr. Hung. 30, 309-316.
13. Osakada F., Hashino A., Kume T., Katsuki H., Kaneko S., and, Akaike A., (2003) Neuroprotective effects of alpha-tocopherol on oxidative stress in rat striatal cultures. Eur. J. Pharmacol. 465, 15-22.
14. Pereira C., Agostinho P., and, Oliveira C. R., (2000) Vinpocetine attenuates the metabolic dysfunction induced by amyloid beta-peptides in PC12 cells. Free Radic. Res. 33, 497-506.
15. Pérez-De La Cruz V., González-Cortés C., Pedraza-Chaverrí J., Maldonado P. D., Andrés-Martínez L., and, Santamaría A., (2006) Protective effect of S-allylcysteine on 3-nitropropionic acid-induced lipid peroxidation and mitochondrial dysfunction in rat brain synaptosomes. Brain Res. Bull. 68, 379-383.
16. Reynolds D., Carter R., and, Morton A., (1998) Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease. J. Neurosci. 23, 10116-10127.
17. Santos M. S., Duarte A. I., Moreira P. I., and, Oliveira C. R., (2000) Synaptosomal response to oxidative stress: effect of vinpocetine. Free Radic. Res. 32, 57-66.
18. Sitges M., and, Nekrassov V., (1999) Vinpocetine selectively inhibits neurotransmitter release triggered by sodium channel activation. Neurochem. Res. 24, 1585-1591.
19. Sitges M., Chiu L. M., and, Nekrassov V., (2007) Effects of carbamazepine, phenytoin, lamotrigine, oxcarbazepine, topiramate and vinpocetine on Na+ channel-mediated release of [3H]glutamate in hippocampal nerve endings. Neuropharmacology 52, 598-605.
20. Sitges M., Aldana B. I., Chiu L. M., and, Nekrassov V., (2009) Characterization of phenytoin, carbamazepine, vinpocetine and clorgyline simultaneous effects on sodium channels and catecholamine metabolism in rat striatal nerve endings. Neurochem. Res. 34, 470-479.
21. Trejo F., Nekrassov V., and, Sitges M., (2001) Characterization of vinpocetine effects on DA and DOPAC release in striatal isolated nerve endings. Brain Res. 909, 59-67.
22. Tretter L., and, Adam-Vizi V., (1998) The neuroprotective drug vinpocetine prevents veratridine-induced [Na+]i and [Ca2 + ]i rise in synaptosomes. NeuroReport 9, 1849-1853.
23. Villarán R., Tomás-Camardiel M., de Pablos R., Santiago M., Herrera A., Navarro A., Machado A., and, Cano J., (2008) Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production. Neurotoxicology 29, 244-258.
24. Wang X., and, Quinn P. J., (1999) Vitamin E and its function in membranes. Prog. Lipid Res. 38, 309-336.